Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion

J Am Heart Assoc. 2018 Nov 20;7(22):e010854. doi: 10.1161/JAHA.118.010854.
No abstract available

Keywords: anticoagulation; cardioversion; oral direct thrombin inhibitor; oral factor Xa inhibitors; timing.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / therapeutic use
  • Dabigatran / administration & dosage
  • Dabigatran / therapeutic use
  • Electric Countershock / adverse effects
  • Electric Countershock / methods*
  • Humans
  • Pyrazoles / administration & dosage
  • Pyrazoles / therapeutic use
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use
  • Pyridones / administration & dosage
  • Pyridones / therapeutic use
  • Risk Factors
  • Rivaroxaban / administration & dosage
  • Rivaroxaban / therapeutic use
  • Thiazoles / administration & dosage
  • Thiazoles / therapeutic use
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control
  • Time Factors

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • Rivaroxaban
  • Dabigatran
  • edoxaban